Barcelona backs regenerative medicine
Today in the La Vanguardia newspaper, Josep Corbella devotes an article to Barcelona's support of research with applications in regenerative medicine. Among the labs mentioned, the article makes reference to the Cellular Plasticity and Disease Laboratory of Manuel Serrano, which will study the repair mechanisms of damaged tissue for biomedical applications in several diseases, with a particular emphasis on diabetes, lung fibrosis and cardiac fibrosis. The new lab at IRB Barcelona, which was inaugurated this month, is funded by the Obra Social "la Caixa" and the ICREA Programme of the Government of Catalonia.
Related content
News
Innovaspain, the newspaper specialized in science and innovation, has interviewed Toni Gabaldón, ICREA researcher at IRB Barcelona and the BSC-CNS, regarding his work on evolutionary genomics. "Genomics is expected to play an important role in the medicine of the future," says the scientist. "The true hope is that genomics emerges not only as a means to detect diseases or define a treatment but as a therapeutic tool through which to manipulate genes through transfer technologies or gene modification," he goes on to say.
El Mundo, La Vanguardia, ABC, Expansión, El Punt Avui, Ara, among other media, have published an article about the launch of "Starlife", a new informatics infrastructure. This technology will allow the use of the most advanced computation techniques, such as those applied to detect new genes linked to cancer and rare diseases, or to simulate the behaviour of molecules and thus speed up the drug discovery process.
Link to El Mundo
It’s a joint initiative of IRB Barcelona, the Barcelona Supercomputing Center and the Centre for Genomic Regulation.
“StarLife” is funded by the Catalan Government, through the European Regional Development Fund, and by ”la Caixa”.
